Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

NCT00131313 · clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
180
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

East Valley Hematology and Oncology Medical Group

Collaborators